Covered recipient · General Payments record
DONNA GRIEBEL
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2025
$781,180.26
- Reported across 231 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $110,710.42 | 28 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $73,010.42 | 14 |
| CHIESI USA, INC. | $22,262.50 | 9 |
| INTERCEPT PHARMACEUTICALS, INC. | $12,675.00 | 2 |
| Merck Sharp & Dohme Corporation | $1,625.00 | 2 |
| Teva Pharmaceuticals USA, Inc. | $1,137.50 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2025 201920202021202220232024
Record-level detail is published for PY2025; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $8,906.25 | 02/20/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1201965681 | CMS |
| ABBVIE INC. | $937.50 | 03/05/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1201965683 | CMS |
| ABBVIE INC. | $4,531.25 | 04/09/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1201965685 | CMS |
| ABBVIE INC. | $9,531.25 | 05/09/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1201965687 | CMS |
| ABBVIE INC. | $3,437.50 | 06/13/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1201965689 | CMS |
| ABBVIE INC. | $5,625.00 | 06/23/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1201965691 | CMS |
| ABBVIE INC. | $1,875.00 | 07/11/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1201965693 | CMS |
| ABBVIE INC. | $3,479.17 | 07/14/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1201965695 | CMS |
| ABBVIE INC. | $1,093.75 | 08/13/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1201965697 | CMS |
| ABBVIE INC. | $8,750.00 | 08/18/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1201965699 | CMS |
| ABBVIE INC. | $1,875.00 | 09/26/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1201965701 | CMS |
| ABBVIE INC. | $3,750.00 | 10/24/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1201965703 | CMS |
| ABBVIE INC. | $9,218.75 | 12/01/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1201965705 | CMS |
| ABBVIE INC. | $10,000.00 | 12/19/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1201965707 | CMS |
| Chiesi USA, Inc. | $2,600.00 | 01/30/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1242160081 | CMS |
| Chiesi USA, Inc. | $3,575.00 | 03/06/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1242160083 | CMS |
| Chiesi USA, Inc. | $1,625.00 | 03/27/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1242160085 | CMS |
| Chiesi USA, Inc. | $650.00 | 04/24/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1242160087 | CMS |
| Chiesi USA, Inc. | $1,300.00 | 05/29/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1242160089 | CMS |
| Chiesi USA, Inc. | $5,687.50 | 08/14/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1242160091 | CMS |
| Chiesi USA, Inc. | $487.50 | 08/28/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1242160093 | CMS |
| Chiesi USA, Inc. | $3,250.00 | 10/30/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1242160095 | CMS |
| Chiesi USA, Inc. | $3,087.50 | 11/25/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1242160097 | CMS |
| Intercept Pharmaceuticals, Inc. | $6,337.50 | 03/14/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1249870646 | CMS |
| Intercept Pharmaceuticals, Inc. | $6,337.50 | 03/14/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1249870648 | CMS |
| Merck Sharp & Dohme LLC | $650.00 | 04/21/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1238041167 | CMS |
| Merck Sharp & Dohme LLC | $975.00 | 07/21/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1238035128 | CMS |
| Teva Pharmaceuticals USA, Inc. | $1,137.50 | 01/02/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1247451388 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.